Trial intelligence / Profile preview

SMUP-IA-01 in Patients With Knee Osteoarthritis

NCT05182034Phase 2Completed

Sponsor
MEDIPOST
Start
Feb 2022
Primary completion
Oct 2023
Modality
Mesenchymal Stem Cells
Countries
1
01

Overview

A Phase 2 trial of SMUP-IA-01 in knee osteoarthritis (OA), sponsored by MEDIPOST. Started Feb 2022; status: completed.

02

Drugs

SMUP-IA-01
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT05182034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05182034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call